Lantheus Holdings, Inc. (LNTH)
80.56
-0.87
(-1.07%)
USD |
NASDAQ |
Apr 10, 15:59
80.56
0.00 (0.00%)
After-Hours: 17:28
Lantheus Holdings EPS Diluted (Quarterly) : 0.8156 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.0199 |
| BioCryst Pharmaceuticals, Inc. | 1.121 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Plus Therapeutics, Inc. | -1.03 |
| BioStem Technologies, Inc. | -0.67 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 54.09M |
| Revenue (Quarterly) | 406.79M |
| Total Expenses (Quarterly) | 352.70M |
| Enterprise Value | 5.565B |
| Gross Profit Margin (Quarterly) | 59.21% |
| Profit Margin (Quarterly) | 13.30% |
| Earnings Yield | 4.18% |
| Operating Earnings Yield | 5.60% |
| Normalized Earnings Yield | 4.295 |